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ABSTRACT During host cell invasion, the eukaryotic pathogen Toxoplasma gondii
forms a parasitophorous vacuole to safely reside within the cell, while it is parti-
tioned from host cell defense mechanisms. From within this safe niche, parasites
sabotage multiple host cell systems, including gene expression, apoptosis, and intra-
cellular immune recognition, by secreting a large arsenal of effector proteins. Many
parasite proteins studied for active host cell manipulative interactions have been ki-
nases. The translocation of effectors from the parasitophorous vacuole into the host
cell is mediated by a putative translocon complex, which includes the proteins
MYR1, MYR2, and MYR3. Whether other proteins are involved in the structure or reg-
ulation of this putative translocon is not known. We have discovered that the se-
creted protein GRA44, which contains a putative acid phosphatase domain, interacts
with members of this complex and is required for host cell effects downstream of
effector secretion. We have determined that GRA44 is processed in a region with ho-
mology to sequences targeted by protozoan proteases of the secretory pathway and
that both major cleavage fragments are secreted into the parasitophorous vacuole.
Immunoprecipitation experiments showed that GRA44 interacts with a large number
of secreted proteins, including MYR1. Importantly, conditional knockdown of GRA44
resulted in a lack of host cell c-Myc upregulation, which mimics the phenotype seen
when members of the translocon complex are genetically disrupted. Thus, the puta-
tive acid phosphatase GRA44 is crucial for host cell alterations during Toxoplasma in-
fection and is associated with the translocon complex which Toxoplasma relies upon
for success as an intracellular pathogen.
IMPORTANCE Approximately one-third of humans are infected with the parasite
Toxoplasma gondii. Toxoplasma infections can lead to severe disease in those with a
compromised or suppressed immune system. Additionally, infections during preg-
nancy present a significant health risk to the developing fetus. Drugs that target this
parasite are limited, have significant side effects, and do not target all disease
stages. Thus, a thorough understanding of how the parasite propagates within a
host is critical in the discovery of novel therapeutic targets. Toxoplasma replication
requires that it enter the cells of the infected organism. In order to survive the envi-
ronment inside a cell, Toxoplasma secretes a large repertoire of proteins, which hi-
jack a number of important cellular functions. How these Toxoplasma proteins move
from the parasite into the host cell is not well understood. Our work shows that the
putative phosphatase GRA44 is part of a protein complex responsible for this pro-
cess.
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Toxoplasma gondii is an obligate intracellular eukaryotic pathogen infecting anestimated one-third of the human population globally. Approximately 15% of the
U.S. population is positive for Toxoplasma infection (1), while some countries in Europe
and South America have much higher infection rates. Within the human host, Toxo-
plasma exists as either highly proliferative tachyzoites, which are responsible for the
acute stage of the infection, or latent bradyzoite cysts, which form in various tissues and
which establish a chronic infection. While most infections are asymptomatic, in immu-
nocompromised individuals and lymphoma patients, new infections or reactivation of
preexisting cysts can lead to toxoplasmic encephalitis, among other complications
(2–4). Additionally, a primary infection puts pregnant women at risk of passing parasites
to the developing fetus, which can cause miscarriage and severe birth defects (5).
Due to its biological niche as an obligate intracellular parasite, Toxoplasma depends
upon remodeling the host cell environment to facilitate its own growth and survival. As
the parasite invades a host cell, it forms an insular vacuole, known as the parasito-
phorous vacuole (PV), within which it may safely replicate undisturbed by host cell
innate immune machinery. Within the PV, parasites interface with the host cell through
the PV membrane (PVM) while avoiding direct contact with host cell components.
Mediation of interactions between parasites and the host cell is accomplished by a
multitude of parasite proteins that are secreted during invasion from the rhoptries (ROP
proteins) and during intracellular division from the dense granules (GRA proteins).
Many of these proteins are secreted beyond the PV into the host cell to directly
manipulate host processes, like transcription, apoptosis, immune responses, and me-
tabolism (6, 7). Additional proteins are secreted but are retained within the PV for the
purpose of trafficking these effectors to the host cytoplasm. The proteins MYR1, MYR2,
and MYR3, components of a putative translocon system, are secreted into the PV and
are responsible for altering a wide array of host processes by trafficking effectors to the
host (8). Secreted proteins, especially those with enzymatic activity, such as kinases and
phosphatases, are of great interest, as they hold potential as drug targets due to their
exclusivity to apicomplexans and importance to parasite survival. Two kinases secreted
during invasion and intracellular growth that are known to be critical for host manip-
ulation and parasite virulence are ROP16 (9) and ROP18 (10). The ROP16 kinase acts to
downregulate STAT3/6 in the host nucleus, which results in altered transcription (11).
ROP18, in partnership with GRA7, counteracts host cell immune responses by phos-
phorylation and inactivation of host immunity-related GTPase (IRG) proteins, which
otherwise act to signal PV degradation (12). Other Toxoplasma kinases known to be
secreted into the host cell include WNG1 and WNG2, formerly ROP35 and ROP34,
respectively (13). Additionally, several pseudokinases have been shown to be secreted
into the host and are implicated in host cell manipulation, such as ROP5, which
complexes with ROP18, conferring binding affinity to host IRGA6 (12).
Whether secreted phosphatases play a role similarly as important as that of secreted
kinases and pseudokinases remains largely unexplored. The secreted phosphatase
PP2C has been proposed to reduce the apoptosis of infected host cells (14), and the
phosphatase PP2C-hn has been found in the host nucleus (15), although its function
remains unclear. To expand our understanding of phosphatases secreted into either the
host cell or PV, we bioinformatically identified 32 proteins predicted to have both a
phosphatase domain and a signal sequence. Of those identified, we characterized the
biological role of TGGT1_228170, which was previously identified to be part of the inner
membrane complex and which was named IMC2A by Mann and Beckers (16). However,
contrary to the initially documented localization, this protein contains characteristics of
secreted proteins, namely, a signal sequence and predicted Toxoplasma export element
(TEXEL) motifs, protease cleavage sites found in many Toxoplasma secreted proteins
(17). Here, we show that this protein is both processed and secreted into the PV, where
it interacts with the proposed translocation complex of MYR1/2/3. Importantly, we
show that TGGT1_228170, now renamed GRA44, is critical for activation of the host
oncogenic factor c-Myc.
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RESULTS
Bioinformatic search for secreted phosphatase. To begin identifying putative
secreted phosphatases, we used a bioinformatics approach starting with all proteins
annotated in the ToxoDB Toxoplasma gondii genome database (toxodb.org). A search
of all Toxoplasma genes with the BLAST program, filtered by including only genes
whose products contain predicted phosphatase domains and signal peptides, gener-
ated a list containing 32 proteins of potential interest (see Table S1 in supplemental
material). To prioritize our studies on phosphatases that are likely to play an important
role in parasite propagation, we ranked our list according to the gene fitness scores
assigned through a genome-wide CRISPR/Cas9 knockout study (18). Among these was
TGGT1_228170, a protein that contains a predicted acid phosphatase domain (Fig. 1A)
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FIG 1 TGGT1_228170 is processed and secreted into the parasitophorous vacuole. To determine the localization
of TGGT1_228170, we introduced a C-terminal HA epitope tag in the endogenous gene. (A) Schematic showing the
relative positions of the signal peptide (SP), the phosphatase domain (Metallophos), and the two putative TEXEL
cleavage sites at amino acids 1205 to 1209 and amino acids 1348 to 1352. The C-terminal HA epitope tag is also
shown. Below the schematic are the sequences of the TEXEL1 and TEXEL2 cleavage domains compared to the
consensus sequence of the TEXEL domain. (B) Western blot of protein lysates from intracellular (Int) and
extracellular (Ext) parasites of the TGGT1_228170(HA)-expressing strain probed with antibodies against HA. Two
stable forms, labeled long and short, are detected. (C) Heat map illustrating the relative positions of peptide-to-
spectrum matches (PSMs) from mass spectrometric analysis of the long and short forms of TGGT1_228170(HA) in
respect to the full protein and the putative cleavage sites. (D) Immunofluorescence assay (IFA) of intracellular
parasites of the IFA images of strain expressing TGGT1_228170(HA) stained for the parasitophorous vacuole protein
GRA7 (in magenta) and for HA (in yellow). Bars 2 m.
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and, that despite having a signal sequence, was previously described as localizing to
the inner membrane complex (IMC) (16). However, multiple lines of evidence suggest
that it may indeed be secreted. First, the homologous protein UIS2 in the related
apicomplexan parasite Plasmodium berghei has been shown to have a secreted or-
tholog (Pf3D7_1464600) in Plasmodium falciparum (19). Second, TGGT1_228170 has
been repeatedly detected in BioID experiments as an interactor of proteins localized to
the PV lumen and PV membrane microenvironments (20). Finally, analysis of the protein
sequence revealed multiple putative Toxoplasma export elements (TEXEL), and at the
time that this investigation began, the sequence was defined as RXLXD/E (21) and has
since been refined as RRL (22). TEXEL sequences are recognized by a Golgi apparatus-
associated protease, aspartyl protease V (ASP5), which cleaves proteins as part of the
secretory pathway to the PV/PV membrane (PVM) and host cell. Based on these criteria
and the fact that TGGT1_228170 was assigned a gene knockout fitness score of 3.28
(18), indicating that it substantially contributes to parasite fitness, we decided to revisit
the localization and function of this protein.
TGGT1_228170 is processed and secreted into the parasitophorous vacuole. To
determine the localization of TGGT1_228170, we introduced sequences encoding three
C-terminal hemagglutinin (HA) epitope tags (3HA) into the endogenous gene by
homologous recombination (Fig. 1A). Western blot analysis of protein extract from both
intracellular and extracellular parasites of the TGGT1_228170(HA) line showed a band
of approximately 180 kDa, which is the expected size for the full protein (Fig. 1B).
However, a second prominent band at approximately 40 kDa was also noted in both
intracellular and extracellular parasites (Fig. 1B). This second, smaller band is consistent
with processing at either of two areas with homology to TEXEL sites (Fig. 1A). The
sequence for the first of these putative cleavage sites is RELEE (amino acids 1205 to
1209), which is consistent with the previous TEXEL consensus sequence, while the
sequence for the second is RRLLE (amino acids 1348 to 1352), which is consistent with
the RRL consensus sequence (Fig. 1A).
To confirm the identity of the 40-kDa fragment observed in the Western blot,
endogenously tagged TGGT1_228170 was immunoprecipitated and the eluate was
separated by SDS-PAGE. Both the 180-kDa (long) and 40-kDa (short) bands were
excised from the PAGE gel and analyzed separately by mass spectrometry (MS). The
results confirmed that both bands corresponded to TGGT1_228170. For the long form,
we detected 192 peptides distributed throughout the full protein sequence (Fig. 1C).
MS analysis of the band migrating to 40 kDa revealed 74 peptides corresponding to
TGGT1_228170, and 60 of these were located after the second putative cleavage site
(Fig. 1C). Thus, TGGT1_228170 is processed, and both the full-length and C-terminal
forms are stable.
Finally, to determine the localization of TGGT1_228170, we performed immunoflu-
orescence assays (IFAs) of TGGT1_228170(HA) parasites. Consistent with the presence
of a signal sequence and putative TEXEL sites, TGGT1_228170 was detected within the
PV lumen and at the PV membrane (PVM) (Fig. 1D). Based on this localization and
corroborative findings by Coffey et al. for the same protein (13), TGGT1_228170 should
be designated a GRA protein, and we henceforth refer to it as GRA44.
Amino acids 1348 to 1352 are required for efficient processing of GRA44. We
hypothesized that the small C-terminal fragment of GRA44 detected by Western
blotting and MS is the product of cleavage at either of the two putative TEXEL
sequences. To investigate which of the two sites is actively cleaved, we exogenously
expressed GRA44 in which the first arginine of either or both of these sites was mutated
to alanine (Fig. 2A). The first arginine of TEXEL sites has previously been shown to be
important for cleavage (21). Western blot analysis showed that mutating the first
arginine of the first putative site (GRA44 R1205A) did not affect processing of the
protein (Fig. 2B). In contrast, mutating the arginine in the second site (GRA44 R1348A)
significantly reduced processing (Fig. 2B). The same result was observed when both
putative TEXEL sites were mutated (GRA44 R1205A/R1348A) (Fig. 2B). Densitometry
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analysis showed that while for the wild-type protein 82.9% 9.9% (n 3) of the total
protein was cleaved, the cleavage in GRA44 R1348A was 47.4% 9.9% (n 3) (Fig. 2C).
Thus, it appears that the second TEXEL is the site for processing of GRA44, and it is
referred to as the GRA44 TEXEL from here on. For a thorough examination of the
identified TEXEL, we generated parasites exogenously expressing GRA44 in which
either L1350 or E1352 was mutated to alanine (Fig. S1A). As was the case for the R1348A
mutation, changing the central leucine in the GRA44 TEXEL to an alanine disrupted
processing (Fig. S1B); however, mutant E1352A showed similar levels of processing as
the wild-type protein (Fig. S1B).
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FIG 2 The second putative TEXEL motif is critical for efficient processing of GRA44. To determine the site
responsible for the processing of GRA44, we expressed exogenous copies of GRA44(HA) in which the first
arginine of the putative cleavage sites was mutated to alanine individually (R1205A and R1348A) or in
combination (R1205A/R1348A) or in which the 5 amino acids of the second putative site were deleted
(Δ1348–1352). (A) Diagram of the TEXEL consensus sequence and the putative sites in GRA44, with the
mutated amino acids indicated in red. (B) Western blot of lysates from parasites expressing the
exogenous GRA44(HA), the R1205A or R1348A mutant version, or the double R1205A/R1348A mutant
probed for HA. (C) (Left) Western blot of lysates from parasites expressing an exogenous copy of GRA44
lacking the second site (the Δ1348–1352 mutant) probed with antibodies against the HA epitope tag.
(Right) Percent cleavage in the wild-type, R1205A, and Δ1348–1352 strains, which was determined by
calculating the ratio of the density of the large band (L) over the sum of the density of both bands (SL).
The results for all data sets (n 3, mean  SD) were significantly different from those for the others,
based on one-way analysis of variance (P 0.05). (D) Representative images of intracellular parasites
expressing each of the four GRA44 processing mutants. Images are of the immunofluorescence signal
from the HA tag (in yellow) and of the HA signal overlaid on the phase image. Bars 2 m.
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Although we observed a significant reduction in cleavage after altering single amino
acids in the GRA44 TEXEL, there appeared to be some residual C-terminal cleavage
product present with all mutants (Fig. 2B and Fig. S1B). To ascertain whether this was
the effect of persistent cleavage at TEXEL, despite the mutations, or cleavage at an
alternative site, we generated an exogenously expressed GRA44 mutant in which all 5
amino acids that make up this TEXEL (amino acids 1348 to 1352) were deleted (the
GRA44 Δ1348–1352 mutant). As expected, deletion of the TEXEL resulted in a signifi-
cant loss of the C-terminal cleavage product (Fig. 2C). However, it was evident that
there still remained a measurable amount being cleaved. The cleavage level for the
Δ1348–1352 mutant was calculated to be 21.1 7.7 (n 3), which was significantly
lower than that for the R1348A point mutant (Fig. 2C). Since the TEXEL was not present
in this mutant form of GRA44, it is plausible that a cryptic site, potentially amino acids
1205 to 1209, was used. Alternatively, GRA44 may be cleaved by a TEXEL/ASP5-
independent mechanism.
To determine whether effective processing is needed for the localization of GRA44
to the PV, we performed IFAs with parasites expressing each of the four mutant GRA44
proteins (the R1205A, R1348A, R1205A/R1348A, and Δ1348–1352 mutants). Interest-
ingly, none of the mutations affected secretion and localization to the parasitophorous
vacuole (Fig. 2D). Similarly, mutating L1350 or E1352 within the confirmed TEXEL site
did not affect the PV localization of GRA44 (Fig. S1C). These results indicate that
complete processing is not required for protein secretion.
Both the N-terminal and C-terminal GRA44 cleavage products localize within
the PV. As the localization analysis performed depended on a C-terminal HA epitope
tag and GRA44 is cleaved at an internal TEXEL site, we could detect only the full-length
uncleaved protein and a smaller C-terminal fragment. Consequently, with the
C-terminal HA-tagged protein, we could not determine the localization of the
N-terminal cleavage product, which contains the putative acid phosphatase domain.
Accordingly, we engineered a strain exogenously expressing GRA44 containing a MYC
epitope tag inserted between amino acids 1203 and 1204, in addition to the HA
epitope tag at the C terminus (Fig. 3A). Protein extracts from parasites expressing the
dually tagged GRA44 were analyzed by Western blotting and probed separately with
antibodies against the MYC or HA epitope (Fig. 3B). Probing of anti-MYC uncovered a
band at approximately 140 kDa, in addition to the 180-kDa full-length protein (Fig. 3B).
This 140 kDa correlates to the expected N-terminal end of GRA44 postcleavage. As
observed previously, probing with antibodies against the HA epitope revealed the
full-length GRA44 and the C-terminal fragment. Having established a parasite line that
allows monitoring of two postprocessing fragments of GRA44, we investigated their
respective localization by IFA. Regardless of whether we used HA or MYC antibodies,
the protein was localized primarily to the PV, which suggests that the two major
fragments, including the one containing the phosphatase domain, are secreted into the
parasitophorous vacuole (Fig. 3C).
Loss of GRA44 negatively affects parasite propagation. Through a genome-wide
CRISPR screen, GRA44 was assigned a log2 relative fitness score of 3.28 (18), which
would suggest that the loss of GRA44 would be a significant detriment to parasite
propagation. Accordingly, we applied a tetracycline (Tet)-repressible system (23, 24) to
establish a conditional GRA44 knockdown strain. Specifically, we used CRISPR to
introduce a cassette encoding a drug-selective marker, a transactivator (TATi) protein,
and a tetracycline response element (TRE) just upstream of the endogenous GRA44
start codon (Fig. 4A). To be able to monitor GRA44 protein expression, we engineered
the conditional knockdown mutant using the GRA44(HA) strain. The resulting strain,
TATi-GRA44(HA), was grown for 24 and 48 h in the absence and presence of the
tetracycline analog anhydrotetracycline (ATc), and GRA44 expression was monitored by
Western blotting (Fig. 4B) and IFA (Fig. 4C). At both time points, protein levels were
significantly reduced in the presence of ATc when observed by either Western blotting
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or IFA (Fig. 4B and C). Thus, we successfully established a strain in which the expression
of GRA44 could be conditionally turned down.
Interestingly, we noted that the small C-terminal fragment from the TATi-GRA44(HA)
strain was smaller than what is observed with the parental endogenous HA-tagged
strain (Fig. 1B and 4B). Sequencing of GRA44 in the TATi-GRA44(HA) strain showed that
a 315-bp fragment, which encodes the last 105 amino acids, was deleted, leaving the
HA tag in frame. Surprisingly, we did not note any significant propagation defect and
successfully complemented the strain with a full-length gene construct (Fig. 4D;
compare the results for the parental strain to those for the knockdown strain grown
without ATc). Thus, deletion of that region does not affect localization or function.
Regardless, this strain allows us to study the consequence of eliminating GRA44
expression upon ATc addition. In addition, to ensure that any phenotype is due to the
downregulation of GRA44, we complemented this strain with the addition of a wild-
type copy of the gene (see below). Importantly, when the TATi-GRA44(HA) strain was
grown in the presence of ATc, depleting GRA44, propagation was significantly affected
compared to the propagation by the same strain under normal conditions (Fig. 4D). For
the conditional knockdown strain, in the absence of ATc, we quantitated an average
cell clearance of 19.4% 9.9%, which was reduced to 0.9% 0.4% when ATc was
included in the growth medium (Fig. 4D). Therefore, the conditional knockdown of
GRA44 significantly reduces parasite propagation in tissue culture.
Processing is not necessary for GRA44 function. To confirm that the propagation
defect observed upon knockdown of GRA44 was due to the reduction of GRA44 levels,
we tested whether an exogenous copy of GRA44 could complement the phenotype.
For this purpose, we introduced a copy of GRA44 with a C-terminal MYC epitope tag
into the TATi-GRA44(HA) strain to generate a complemented strain, TATi-
GRA44(HA)comp, (Fig. 5A). The exogenous copy of GRA44(MYC) was processed and
secreted as expected (Fig. 5B and C). In the absence of ATc, both the endogenous
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FIG 3 The GRA44 N-terminal cleavage product is secreted. To determine the stability and localization of
the GRA44 N-terminal cleavage product, we expressed an exogenous copy of GRA44 with an internal
MYC epitope tag and a C-terminal HA epitope tag. (A) Schematic of the exogenous GRA44 construct
MYC-TXL-HA showing the positions of the MYC and HA epitope tags relative to the two putative cleavage
sites. (B) Western blot of the MYC-TXL-HA parasite line separately probed with anti-HA and anti-MYC
antibodies. (C) IFA images of MYC-TXL-HA-expressing parasites probed for HA (yellow) and MYC
(magenta). Bar 2 m.
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HA-tagged GRA44 and the exogenous MYC-tagged GRA44 were detected in this strain
by both Western blotting and IFA (Fig. 5B and C). As expected, addition of ATc resulted
in the knockdown of GRA44(HA) but not that of the exogenous GRA44(MYC) (Fig. 5B
and C). Plaque assays of both the knockdown [TATi-GRA44(HA)] and complemented
[TATi-GRA44(HA)comp] strains with and without ATc were performed in parallel to
determine the ability of GRA44 to complement the phenotype. Consistent with the
previous result, addition of ATc to the TATi-GRA44(HA) strain severely impaired plaque
formation (Fig. 5D). Importantly, the presence of a constitutively expressed copy of
GRA44 complemented this phenotype (Fig. 5D). While the percent clearance of the host
cell in the presence of ATc was 0.8% 0.4% for the knockdown strain after 5 days in
culture, it was 26.6% 3.7% for the complemented strain, which was statistically equal
to what was observed without ATc with either strain (Fig. 5D). Complementation of the
plaque formation phenotype by the addition of a wild-type copy confirms that GRA44
is critical for the efficient propagation of Toxoplasma.
Having established complementation of the propagation phenotype, we set out to
determine whether processing of GRA44 was needed for function. Accordingly, we
complemented the TATi-GRA44(HA) strain with an exogenous copy of GRA44(MYC)
containing a TEXEL deletion of residues 1348 to 1352 to obtain the strain
GRA44compΔTXL. For the GRA44compΔTXL strain under normal growth conditions
without ATc, endogenous GRA44(HA) was detected by Western blotting at a size similar
to that in the TATi-GRA44 and TATi-GRA44comp strains; however, the exogenous
MYC-tagged GRA44compΔTXL copy was seen as a mostly uncleaved form of the
protein, in contrast to that in the wild-type complemented strain, which was processed
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FIG 4 Knockdown of GRA44 disrupts parasite propagation. To determine the function of GRA44, we
applied a tetracycline (Tet)-repressible system to establish a conditional GRA44 knockdown strain. (A)
Diagram of the strategy used to generate the conditional knockdown of GRA44, as outlined in the
Materials and Methods section. Sel marker, selective marker. (B) Quantitative Western blot of the
TATi-GRA44(HA) parasite strain grown for either 24 or 48 h in the absence (lanes ) or the presence
(lanes ) of ATc probed with HA to detect GRA44 and SAG1 as a loading control. (C) The reduction in
GRA44 expression in the presence of ATc was confirmed by IFA of intracellular parasites of the
TATi-GRA44(HA) strain grown with and without ATc for 24 or 48 h and probed with anti-HA antibodies.
Bars 2 m. (D) Plaque assays were performed with the GRA44(HA) parasites (parental) or the TATi-
GRA44(HA) parasites grown without () or with () ATc for 5 days. (Left) Representative results of a
plaque assay. (Right) The results were quantitated based on the percentage of the cell monolayer cleared
by the parasite (cleared area) and the average for biological and experimental triplicates (n 3; mean 
SD; P 0.0001, unpaired t test).
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FIG 5 The phenotype of GRA44 knockdown can be complemented. To establish a direct connection
between the lack of GRA44 and the phenotype observed, we established a complemented strain by
adding an exogenous copy of wild-type GRA44 to the TATi-GRA44(HA) conditional knockdown strain. (A)
Diagram of the strategy used to establish a complemented strain, TATi-GRA44(HA)comp. The wild-type
copy of GRA44 added to the TATi-GRA44(HA) strain contains a C-terminal MYC epitope tag and is driven
by the Toxoplasma tubulin promoter (tub). (B) Western blot of lysates from the TATi-GRA44(HA)comp
parasites grown with and without ATc for 48 h. The blots were probed for HA and MYC. (C) Represen-
tative IFA images of TATi-GRA44(HA)comp with and without ATc treatment stained for the HA-tagged
regulatable GRA44 and the MYC-tagged constitutive exogenous copy. Bars 2 m. (D) (Left) Plaque
assays were performed with the knockdown [TATi-GRA44(HA)] and the complemented [TATi-
GRA44(HA)comp] strains grown without () or with () ATc for 5 days. (Right) The average percentage
of the cell monolayer cleared from biological and experimental triplicates is shown on a bar graph (n 3;
mean  SD; ****, P 0.0001; n.s., not significant [significance was determined by one-way analysis of
variance, followed by Tukey’s test]). (E) TATi-GRA44(HA) was complemented with an exogenous copy of
GRA44 containing TEXEL with a deletion of amino acids 1348 to 1352 and a C-terminal MYC tag
[TATi-GRA44(HA)compΔTXL]. Lysates from TATi-GRA44(HA), wild-type complemented strain TATi-
GRA44(HA)comp, and ΔTXL complemented strain TATi-GRA44(HA)compΔTXL were analyzed by Western
blotting and probed for HA and MYC. (F) Plaque assays were performed with the TATi-GRA44(HA) and
TATi-GRA44(HA)compΔTXL strains. Parasites were grown 5 days without () or with () ATc. The average
percentage of the cell monolayer cleared for biological and experimental triplicates is shown on a bar
graph (n 3; mean  SD; ****, P 0.0001; n.s., not significant [significance was determined by one-way
analysis of variance, followed by Tukey’s test]).
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(Fig. 5E). Remarkably, the GRA44compΔTXL complemented parasite strain was no
longer sensitive to the presence of ATc (Fig. 5E). These results indicate that the
complete cleavage of GRA44 is not necessary for function.
GRA44 interacts with members of the effector translocation complex. Our
results have thus far shown GRA44 to be of significant importance for successful
parasite propagation; however, the specific function of this protein within the parasi-
tophorous vacuole is unclear. To shed light on its function, we examined what proteins
interact with GRA44 by developing a comprehensive interactome. For this purpose, the
GRA44 protein was immunoprecipitated from the HA-tagged GRA44(HA) line and
coprecipitating peptides were analyzed by mass spectrometry. After three replicate
experiments and control assays with nonspecific beads, the data were statistically
analyzed by significant analysis of interactome (SAINT) (25) computational predictive
analysis (Data Set S1). With a SAINT score of 0.8 used as a cutoff, we obtained a list
of 35 putative interactors, of which 8 were ribosomal and snRNP proteins and likely to
be nonspecific (Table S2). Significantly, of the remaining 27 putative interactors, 23 had
predicted signal peptides, which indicates that they are likely secreted proteins (Ta-
ble 1). Among these were eight known GRA proteins (GRA9, -16, -25, -33, -34, -45, -50,
and -52); the parasitophorous vacuole membrane-associated protein MAF1; and MYR1,
a known member of the effector translocation complex (26, 27).
To confirm the interaction with MYR1, for which there are antibodies (26), we
performed coimmunoprecipitation (co-IP) assays. Purified lysate was precipitated from
GRA44(HA) parasites on mouse anti-HA beads, and the eluates were evaluated by
Western blotting for the presence of GRA44 and MYR1. For MYR1, which is also
processed by ASP5 at a TEXEL site, we probed with antibodies for either the C-terminal
or the N-terminal cleavage product. Immunoprecipitated GRA44 yielded a significant
amount of either MYR1 fragment compared to that for the control IgG bead eluate of
the same source (Fig. 6). Thus, GRA44 appears to interact with a member of the effector
translocation system.
TABLE 1 Putative GRA44 interactors identified by IPa
Protein Product description
TGGT1_316250 GRA45
TGGT1_204340 GRA54
TGGT1_254470 MYR1
TGGT1_319340 GRA52
TGGT1_279100 MAF1a
TGGT1_251540 GRA9
TGGT1_203600 GRA50
TGGT1_304955 Serine/threonine-specific protein phosphatase (PPM11C)
TGGT1_315610 Hypothetical protein
TGGT1_203290 GRA34
TGGT1_270320 Protein phosphatase 2C domain-containing protein (PPM3C)
TGGT1_258870 Hypothetical protein
TGGT1_311720 Chaperonin protein BiP
TGGT1_226240 Putative bud site selection protein
TGGT1_216770 Hypothetical protein
TGGT1_220950 MAF1b
TGGT1_270240 MAG1
TGGT1_200360 Hypothetical protein
TGGT1_290700 GRA25
TGGT1_258458 Hypothetical protein
TGGT1_262050 Rhoptry kinase family protein ROP39
TGGT1_410360 MAF1 copy
TGGT1_247440 GRA33
TGGT1_229480 Putative calcium binding protein precursor
TGGT1_208830 GRA16
TGGT1_410370 MAF1 copy
aThe criteria used were a SAINT score (for the signal peptide) of 0.8 and not being a ribosomal protein
(TGGT1_309820, TGGT1_207840, TGGT1_266070, TGGT1_248480). The shaded proteins have a predicted
signal peptide based on SignalP analysis. Proteins are listed on the basis of their SAINT scores, total
peptides, and the fold change in the number of peptides in experimental IPs over that for the controls (see
Table S2 in the supplemental material).
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GRA44 is required for c-Myc induction. MYR1 was identified through a forward
genetic screen to be required for the translocation of parasite effectors, such as GRA16
and GRA24, and the ensuing upregulation of the host cell oncogene c-Myc (26). Given
GRA44’s interaction with MYR1, we tested whether it might be involved in the same
functions, specifically, c-Myc induction. For this purpose, TATi-GRA44(HA) parasites
were grown for 24 h either with or without ATc, released from the host cells, and
allowed to infect new cells. Those that came from the conditions with ATc were kept
in ATc, while those from the culture without ATc were kept without it. After 12 h of
growth, the cultures were fixed and an IFA for human c-Myc was performed (Fig. 7).
Images obtained by merged phase-contrast microscopy and HA, MYC, DAPI (4=,6-
diamidino-2-phenylindole), and c-Myc staining were used to locate host cells infected
by single PVs with greater than 1 parasite per vacuole, and single-channel images of
c-Myc staining within these host nuclei boundaries were quantitated with ImageJ
software. Addition of ATc to TATi-GRA44(HA) parasites produced a significantly reduced
level of GRA44 (Fig. 7A), consistent with the results observed by Western blotting, and,
importantly, reduced the c-Myc signal by approximately 5-fold, a significantly damp-
ened response compared to that seen under normal conditions with the same strain
(Fig. 7B). No significant difference in the c-Myc signal was observed in the comple-
mented strain upon ATc addition.
DISCUSSION
As part of its life cycle, Toxoplasma invades and dwells within host cells, where it
utilizes nutrient resources readily available within a host. Since residence inside a host
is key to parasite survival and propagation, Toxoplasma parasites have multiple means
of altering the status of their host to better suit their needs. Examples of the changes
induced within the host include apoptosis inhibition (14), innate immune system
disruption (28), host cytoskeleton restructuring (29), and global changes to host gene
transcription (9). These critical host cell alterations are accomplished by a large arsenal
of parasite effectors that are secreted into the host cell during invasion and intracellular
division. Secretion of these effectors involves highly coordinated actions by two unique
parasite organelles: the rhoptries and the dense granules. The rhoptries discharge
proteins known as ROPs during invasion, while the dense granules release their
contents into the PV during intracellular division. While some of these so-called GRA
proteins remain within the PV space or associate with the PV membrane (PVM), many
of them are translocated across the PVM into the host, where they affect numerous
signaling pathways. How these proteins move from the PV to the host is becoming
clear with the discovery of proteins that appear to form part of a putative translocon
(24). The work presented here shows that GRA44 (TGGT1_228170), previously known as
A.
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FIG 6 GRA44 interacts with MYR1. To confirm the interaction between GRA44 and MYR1, we performed
immunoprecipitation from GRA44(HA)-expressing parasites and probed for GRA44(HA) (A) or either the
N terminus (B) or the C terminus (C) of MYR1 by Western blotting. As controls, we performed the
immunoprecipitation with IgG-conjugated beads. In all blots, the first lane is whole lysate (WL), the
middle lane is the eluate from IgG beads, and the last lane is the eluate from the HA beads.
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IMC2A (16), interacts with members of this complex and that it is essential for some of
the host cell events downstream of effector translocation.
Work from Coffey et al. identified GRA44 to be a substrate of ASP5 through a
comparative proteomic approach (13). They showed that, indeed, GRA44 is processed
and secreted into the PV, which we have corroborated with the work presented here.
Their analysis of GRA44 identified two cleavage sites, one at positions 83 to 85 and
another at positions 1348 to 1350. Nonetheless, their studies did not determine
whether all cleavage products were secreted or the function/role of GRA44 within the
PV. Here, we report that the two major GRA44 products are secreted into the PV. This
is important, as it is the first evidence that the fragment containing the putative acid
phosphatase is indeed in the PV. In our study, we show that the processing is not
necessary for either the secretion or the function of GRA44. This is consistent with the
fact that other secreted proteins containing TEXEL motifs, such as MYR1 and WNG1/2,
can still be secreted in the absence of ASP5 activity (13). Fortuitously, through a
spontaneous deletion in the knockdown strain, we also determined that the last 105
amino acids of the protein are not needed for function or localization.
Proteomic analysis of proteins that coimmunoprecipitated with GRA44 revealed
interactions with known secreted proteins, including numerous GRAs. Among these
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FIG 7 c-Myc activation in the GRA44 mutant strain. To assess the host cell response upon GRA44 knockdown, host
nuclear c-Myc expression was quantified by fluorescence microscopy after invasion by either the knockdown
TATi-GRA44(HA) or the complemented knockdown TATi-GRA44(HA)comp parasite strain in the presence and the
absence of ATc. (A) Representative immunofluorescence images of TATI-GRA44(HA) parasites grown without ATc
(ATc) or with ATc (ATc). The cultures were stained for HA to detect GRA44 (yellow), DAPI to detect DNA (blue),
and host c-Myc (magenta). Arrows point at vacuoles with more than 2 parasites. (B) The graph represents the
average quantified nuclear signal from c-Myc antibody staining across biological and experimental triplicates.
Arbitrary units (AU) were used in comparing the nuclear c-Myc signal intensity (n  3; ****, P 0.0001; n.s., not
significant [significance was determined by one-way analysis of variance, followed by Tukey’s test]).
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interactors are GRA9, part of the intravacuolar tubular network (30); GRA16, an effector
altering the host cell cycle through the p53 pathway (31); GRA25, a macrophage-
dependent immune modulator (32); and GRA33, GRA34, GRA45, GRA50, GRA52, and
members of the multicopy mitochondrion association factor 1 (MAF1) family. MAF1 is
involved in recruiting the host mitochondria to the PV membrane surface (33). Most
importantly, immunoprecipitation (IP) revealed an interaction between MYR1 and
GRA44, which we independently confirmed by Western blotting (Fig. 6). Interestingly,
as we were studying the interactome of GRA44, we learned of ongoing work in John C.
Boothroyd’s lab showing a physical and functional interaction between MYR1 and
GRA44 (34). MYR1 was initially identified through a forward genetic screen for Toxo-
plasma mutants unable to activate host c-Myc and translocate effectors, such as GRA16
and GRA24 (22). Further screening for such mutants identified MYR2 and MYR3 to also
be required for effector translocation (27). Thus, MYR1/2/3 appear to be part of a
putative translocon complex, although only MYR1 and MYR3 have been confirmed to
directly interact (27). MYR1-dependent effectors are responsible for driving a broad
range of host cell effects early on during infection. MYR1-dependent host responses
include the upregulation of E2F transcription factors and the downregulation of
interferon signaling (8). The interaction between GRA44 and MYR1 would suggest a
function in translocation for this putative acid phosphatase.
One of the challenges in determining the relevance of interactions among dense
granule proteins is that those interactions could be within the dense granules or during
transit and not necessarily once in the PV or host, where they exert their function.
Nonetheless, our data strongly suggest that the interaction with MYR1 is functionally
relevant. Similar to the results obtained after the knockout of MYR1, the knockdown of
GRA44 resulted in a significant reduction of c-Myc activation. Together, these findings
support the notion that GRA44 is a member of the MYR1/2/3 translocon machinery.
Whether its role in this process is structural or regulatory remains unknown and would
require further investigation. The possibility that GRA44 plays a regulatory function is
suggested by the presence of a putative catalytic site reminiscent of acid phosphatases.
Whether GRA44 is an active phosphatase or a pseudophosphatase remains to be
determined.
In the biology of animals, plants, and fungi, acid phosphatases serve many biological
purposes, and proteins are designated as such based on a shared similarity in catalytic
site structural arrangement (35, 36). Typically, these enzymes coordinate an Fe(III) and
a divalent metal, such as Mn(II), Zn(II), or Fe(II), as part of their active site. Each metal
is coordinated to 3 amino acids and shares a linking aspartic acid bridge between them,
with the Fe(III) typically being mated to a histidine, an asparagine, and a tyrosine and
the divalent metal being bound by two histidines and an asparagine (35, 36). Based on
homology alignment of its phosphatase domain, GRA44 contains a majority of the
conserved residues common to acid phosphatases (see Fig. S3 in the supplemental
material). In GRA44, the aspartic acid conjugating the Fe(III) is switched to an aspara-
gine and the asparagine conjugating the second metal is replaced by a glutamic acid.
This would represent a swap in charged amino acids and should still maintain a stable
charge equilibrium within the active site. The only coordinating residue unaccounted
for is the tyrosine binding Fe(III) (Fig. S3). The active site of GRA44 could then be
hypothesized to consist of an Asp bridge between the first metal, M(II), bound by a
glutamic acid and two histidines, and the second metal, M(III), bound by an asparagine,
a histidine, and an unknown seventh residue.
Acid phosphatases commonly scavenge, recycle, and transport inorganic phospho-
rus and have been implicated in various biological functions, such as the downregu-
lation of prostate cell growth signaling and osteoclast bone resorption activity (37, 38).
Acid phosphatases have also been implicated in phosphate acquisition from organo-
phosphate compounds and the dephosphorylative regulation of enzymes in plants (39,
40). The GRA44 function, at least in part, is likely related to its interactions with the MYR
translocon in the PV. Two plausible functions for GRA44 could be regulation of MYR
component proteins by dephosphorylation or the dephosphorylation of effectors for
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trafficking across the PVM structure. Typically, proteins must be dephosphorylated to
cross a lipid bilayer membrane, such as the PVM, and notably, both GRA16 and GRA24
have been shown to be phosphorylated, as identified by Toxoplasma phosphopro-
teome analysis (41). MYR3 also exists in a partial phosphorylated state and could be a
substrate for a phosphatase, such as GRA44 (27). Consistent with the idea of phospho-
regulation of the export system, the secreted kinase ROP17 has been shown to be
critical for efficient effector translocation (42).
Besides the defect in c-Myc activation, the genetic disruption of GRA44 results in a
propagation defect. This result is congruent with published work describing the effect
of complete GRA44 knockout (13) and with the fitness score of 3.28 assigned to
GRA44 through a genome-wide CRISPR screen (18). This is particularly interesting, as
the disruption of other translocon members does not affect fitness to the level seen
with the disruption of GRA44. For example, the relative fitness scores for MYR1, MYR2,
and MYR3 are 0.88, 2.39, and 2.83, respectively, although disruption of any of these
interferes with effector translocation and c-Myc activation. Similarly, disruption of the
effectors GRA16, GRA24, and TgIST, which depend on MYR1 for translocation, have
positive fitness scores of 1.44, 2.28, and 2.86, respectively. Thus, it is unlikely that the
propagation defect exhibited by parasites lacking GRA44 is due to defects on effector
translocation. Alternatively, GRA44 might play several independent roles, including
nutrient acquisition, which would be consistent with the known functions of acid
phosphatases.
In conclusion, we have shown GRA44 to be a secreted protein critical for Toxoplasma
survival and propagation that plays a significant role in host manipulation and that
interacts with the translocon protein MYR1. As part of its secretion to the PV, it is
cleaved at an internal TEXEL site, forming two stable and colocalizing proteins. The
mechanistic action by which GRA44 is involved with protein secretion to host cells
remains unknown; however, due to its putative acid phosphatase domain, involvement
with the dephosphorylation of trafficked proteins or members of the translocon
complex is plausible. Future work on the activity and substrates of GRA44 will shed light
on the regulation of effector translocation, a process central to the interactions be-
tween Toxoplasma and its host.
MATERIALS AND METHODS
Parasite and host cell culture. All parasite lines were maintained by continuous passage through
human foreskin fibroblasts (HFFs), purchased from ATCC. Parasites and HFFs were grown in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM/liter glutamine,
100 units penicillin/ml, and 100 g streptomycin/ml. When pyrimethamine was included in the medium
for selection, dialyzed FBS was used. All parasite and HFF cultures were grown in a humidified incubator
at 37°C with 5% CO2. The initial parental parasite lines used were the RH strain lacking the hypoxanthine-
xanthine-guanine phosphoribosyltransferase (HPT) gene, referred to as RHΔhpt (43), and the RH strain
lacking HPT and Ku80, referred to as RHΔku80 (44, 45). For drug treatment and selection, stocks of
pyrimethamine and chloramphenicol were prepared in ethanol and stocks of anhydrotetracycline (ATc)
were prepared in dimethyl sulfoxide. All drugs were purchased from Sigma.
Endogenous epitope tagging. For C-terminal endogenous tagging of TGGT1_228170, the 3= region
directly upstream of the stop codon was amplified from RHΔku80 parasite genomic DNA by PCR and
inserted into the pLIC-3HA-DHFR (45) vector at the PacI restriction site by ligation-independent cloning
(LIC), facilitated by use of an InFusion HD Cloning Plus system (Clontech). The sequences of the primers
for this and all reactions used in this work are presented in Table S3 in the supplemental material. Fifty
micrograms of XcmI-linearized vector was transfected into RHΔku80 parasites, and the resultant popu-
lation was selected for the presence of the pyrimethamine-resistant dihydrofolate reductase (DHFR)
allele, which is included in the vector (46). Independent clones were established by limiting dilution of
the transfected population and confirmed by immunofluorescence assay and Western blotting.
Exogenous gene insertion and parasite line generation. To introduce an exogenous copy of
TGGT1_228170 into parasites, we first generated a vector containing a section of the genomic
TGGT1_228170 locus beginning from the start codon and going to the stop codon that included introns
and a C-terminal HA epitope. The section of TGGT1_228170 in the vector was flanked by the Toxoplasma
tubulin promoter and 5= untranslated region (UTR) and the tubulin 3= UTR. This was achieved by cloning
a PCR amplicon of the TGGT1_228170 genomic DNA (the primers are provided in Table S3) into the NcoI
and PacI sites of pTNRluc-Tub-HPT (47) using the InFusion HD Cloning Plus system for LIC. Fifty
micrograms of the resulting vector, pTub-Gra44-HPT, linearized with ScaI, was transfected into RHΔhpt
parasites. The transfected population was selected for HPT by adding mycophenolic acid (50 g/ml) and
xanthine (50 g/ml) to the medium. Independent clones were established by limiting dilution. For
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mutant variations of the exogenously expressed TGGT1_228170, TEXEL deletions, a MYC epitope tag
insertion, and TEXEL2 point mutations were introduced into pTub-Gra44-HPT using a Q5 site-directed
mutagenesis kit (New England Biolabs [NEB]), and TEXEL point mutations were accomplished similarly
with a QuikChange site-directed mutagenesis kit (Agilent).
Development of GRA44 conditional knockdown parasite line. To generate the GRA44 conditional
knockout strain, we introduced a cassette encoding a drug-selective marker, a transactivator (TATi)
protein, and a Tet response element (TRE) just upstream of the GRA44 start codon. This TATi cassette was
amplified from the vector pT8TATi-Gra44-HX-tetO7S (48) with primers that include areas of homology
upstream of GRA44 to facilitate homologous recombination. One microgram of this PCR amplicon was
transfected into the RHΔku80 parasites that expressed endogenously HA-tagged GRA44. To drive the
insertion of the TATi cassette, we cotransfected the PCR amplicon with 2 g of a vector expressing Cas9
and a guide RNA targeting the TGGT1_228170 locus upstream of the start codon. This vector was made
using pSAG1-Cas9-GFP-pU6-sgUPRT (49) as a template, and the sequences encoding the guide RNA were
introduced with the Q5 site-directed mutagenesis kit (NEB). Parasites transfected with the TATi cassette
and Cas9 vector were selected for HPT, and independent clones were established by limiting dilution.
Correct integration of the TATi insert cassette was validated by PCR. The resulting strain was designated
TATi-GRA44(HA).
Complementation of conditional knockdown line. To complement the knockdown strain, a
wild-type copy of TGGT1_228170 that was driven by a Toxoplasma tubulin promoter and that included
a C-terminal MYC epitope tag was targeted to the inactive ku80 locus of the TATi-GRA44(HA) strain using
CRISPR/Cas9 to assist with integration. The insertional cassette, which includes the tubulin-driven
TGGT1_228170 and a chloramphenicol resistance gene (50), was amplified by PCR from plasmid
pTub-Gra44-myc-CmR with primers that included homology segments to the ku80 locus (Table S3).The
pTub-Gra44-myc-CmR vector was constructed with InFusion HD Cloning Plus system-assisted LIC cloning
by inserting the GRA44 gene with an appended C-terminal MYC tag, amplified from pTub-Gra44-HPT,
into the pLIC-SMGFP-CmR vector backbone (51), replacing the soluble modified green fluorescent
protein (SMGFP) tag and upstream region. One microgram of this PCR amplicon was cotransfected with
2 g of the Cas9 vector encoding a small guide RNA targeting the ku80 locus.
SDS-PAGE and Western blot analysis. For detection of protein in lysates from extracellular parasite
samples, parasites were allowed to undergo natural egress and were then collected, centrifuged, and
washed 2 times with cold phosphate-buffered saline (PBS) (10 min, 1,000 g). For analysis of intracellular
parasite protein lysates, host cell monolayers were washed 2 times with cold PBS, scraped, and
centrifuged for 10 min at 1,000 g. Parasite samples were resuspended in 2 sample loading buffer
with 5% -mercaptoethanol and boiled for 5 min at 98°C. The boiled samples were frozen at 20°C and
then thawed and reboiled for 5 min at 98°C before gel loading. SDS-PAGE and Western blotting were
performed by standard methods, as previously described (52).
For Western blot analysis of GRA44 conditional mutant strains, parasites were first grown under
normal conditions for 24 h and then syringe lysed with a 27-gauge needle. Fresh host cells were infected
with an equal quantity of syringe-lysed parasites and grown for 24 or 48 h with or without 1 g/ml ATc.
For analysis of protein lysates from extracellular parasite samples, host cells were scraped, and parasites
were released by passing them through a syringe and centrifuged for 10 min at 1,000 g. For analysis
of intracellular parasite protein lysates, host cell monolayers were washed with cold PBS, scraped, and
centrifuged for 10 min at 1,000 g. The resulting samples were resuspended in 200 l radioimmuno-
precipitation assay lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1%
Triton X-100) including a protease/phosphatase inhibitor cocktail (Cell Signaling Technology) and
incubated on ice for 1 h, sonicated 2 times for 15 s each time with 1-min rests on ice, and centrifuged
(20,000 g, 15 min, 4°C). The supernatants were combined with 4 SDS loading buffer with 10%
-mercaptoethanol and boiled for 5 min at 98°C. The boiled SDS samples were frozen at20°C and then
thawed and reboiled for 5 min at 98°C before gel loading. SDS-PAGE and Western blotting were
performed by standard methods as described above. Uncropped original images for all Western blots are
included as Data Set S2.
The primary antibodies used for Western blotting included rabbit anti-HA at a dilution of 1:1,000 (Cell
Signaling Technologies), rabbit anti-MYC at a dilution of 1:1,000 (Cell Signaling Technologies), mouse
anti-SAG1 at a dilution of 1:2,000 (Genway), and mouse anti-MYR1 antibodies at 1:1,000 (26, 27). The
secondary antibodies used included peroxidase-conjugated goat antimouse and anti-rabbit immuno-
globulins and were used at a 1:10,000 dilution.
IFAs. For all immunofluorescence assays (IFA), HFFs were grown to confluence on 1.5-mm glass
coverslips and infected with parasites, which were allowed to grow for 20 h prior to fixation with 4%
paraformaldehyde for 20 min. Cells were washed once with PBS after fixation and then permeabilized
and blocked with a solution of 3% bovine serum albumin (BSA)–0.2% Triton X-100 in PBS for 15 to 20
min. Coverslips were incubated with primary antibodies in 3% BSA–0.2% Triton X-100 in PBS for 1 h at
room temperature and washed five times with PBS. Finally, the cultures were incubated with
fluorophore-conjugated secondary antibodies for 1 h at room temperature in 3% BSA in PBS and then
washed five times with PBS and mounted on glass slides with Vectashield mounting medium containing
DAPI (Vector Laboratories). The primary antibodies used were rabbit anti-HA at 1:1,000, mouse anti-MYC
at 1:1,000 (Cell Signaling Technology), rat anti-HA at 1:2,000 (Roche), rabbit anti-human c-Myc at 1:1,000
(Abcam), mouse anti-gra5 (Biotem) at 1:1,000, and mouse anti-gra7 at 1:1,000. The secondary antibodies
used (Life Technologies) were Alexa Fluor 488-conjugated goat anti-rabbit or goat anti-rat immunoglob-
ulin, Alexa Fluor 594-conjugated goat anti-mouse or goat anti-rabbit immunoglobulin, and Alexa Fluor
647-conjugated goat anti-mouse immunoglobulin. All secondary antibodies were used at 1:2,000. Images
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were taken on a Nikon Eclipse 80i microscope using a Nikon DS-Qi1Mc camera and NIS Elements AR
(v3.0) software.
Immunoprecipitation and co-IP experiments. Infected host cells were washed 2 times with cold
PBS and scraped from the flask surface to collect intracellular parasites, which were centrifuged for 10
min at 1,000 g and resuspended in 200 l ice-cold IP lysis buffer (Pierce, Thermo Scientific) containing
protease and phosphatase inhibitors (Cell Signaling Technology). The lysate was incubated on ice for 1
h, sonicated on ice 2 times for 15 s each time, and centrifuged for 15 min at 20,000 g and 4°C. The
supernatant was collected and incubated with magnetic beads conjugated to either mouse IgG or
primary antibody (Pierce, Thermo Scientific) for 1 h at 4°C with rocking. The incubated beads were
separated from the solution with a magnet and washed with IP lysis buffer (Pierce, Thermo Scientific)
plus inhibitors 3 times and either stored in 8 M urea at 80°C for downstream mass spectrometric
analysis or directly eluted into 2 SDS sample loading buffer–5% -mercaptoethanol, boiled for 5 min
at 98°C, and stored at 20°C for Western blot analysis. SDS-PAGE and Western blotting were performed
as outlined above. Protein analysis by mass spectrometry was completed by the Indiana University
School of Medicine Proteomics Core facility as previously described (52).
Plaque assays. Twelve-well plates were infected with 500 parasites/well of freshly syringe-lysed
parasites, and the parasites were grown undisturbed for 5 days before fixation with methanol for 5 min.
The wells were stained with crystal violet, and the plaque images were quantified with ImageJ software
using the ColonyArea plug-in (52).
HFF c-Myc response assay and quantitation. The parasites used for c-Myc assays were grown for
48 h with or without 1 g/ml ATc and syringe lysed prior to infection of host cell coverslips. Coverslips
of confluent HFF monolayers pretreated for 24 h with FBS-free medium were infected and fixed at 19 h
postinfection. IFAs for human c-Myc, HA, and DAPI were performed as described above. Images of
phase-contrast, DAPI, HA, MYC, and c-Myc channels were acquired for at least 20 vacuoles under each
experimental condition and exported to ImageJ software. Infected host cell nuclei were identified from
merged-channel images and quantitated for c-Myc expression from images of the c-Myc channel alone.
Measurements of the mean pixel intensity within host nucleus boundaries of singly infected cells
containing PVs with greater than one parasite were taken. Measurements from triplicate experiments
were averaged.
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